Skip to content

Vascular Effects of Dietary Potassium

Vascular Effects of Dietary Potassium in Humans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03265353
Enrollment
47
Registered
2017-08-29
Start date
2013-07-25
Completion date
2019-09-22
Last updated
2020-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Risk Factor

Keywords

Potassium, Sodium, Vascular function

Brief summary

The purpose of this study is to determine if dietary potassium can attenuate the deleterious effects of high sodium on blood vessel function in healthy, salt-resistant participants.

Detailed description

Cardiovascular disease remains a major Public Health problem in the U.S. and is the result of diseases such as atherosclerosis and high blood pressure (BP). Several dietary factors have been implicated as risk factors including high sodium and low potassium diets. Indeed, it is well known that excess sodium can increase BP while potassium rich diets have BP lowering properties. While the role of these two nutrients on BP is widely accepted, their impact on the vasculature has received less attention. Endothelial dysfunction, characterized by impaired dilation is an important non-traditional risk factor for atherosclerosis. Data in animal models suggest that salt loading, independent of changes in BP, results in endothelial dysfunction while evidence is mounting that potassium may be beneficial to vascular health. Further, potassium may be more effective in the presence of high sodium however the role of potassium in protecting the vasculature from a high sodium diet in salt-resistant adults has not been explored. A potential mechanism responsible for sodium induced vascular dysfunction is overproduction of reactive oxygen species resulting in reduced nitric oxide (NO) production/ bioavailability. It has been suggested that potassium can counteract sodium's effect by reducing ROS. The central hypothesis is that potassium can protect against the deleterious effects of high sodium on the vasculature by reducing oxidative stress and preserving NO. In this grant, the investigators propose to use a 21-day controlled feeding study to compare the effects of a high sodium diet (300 mmol) combined with either a high (120 mmol) or moderate (65 mmol) amount of potassium and low sodium (50 mmol) combined with moderate potassium (crossover design, diet order sequence randomized) on 2 levels of the vasculature, conduit artery and microvasculature. These experiments will be performed in salt-resistant participants to study the vascular effects alone, independent of changes in BP.

Interventions

7 days of the prescribed diet

7 days of the prescribed diet

7 days of the prescribed diet

Sponsors

University of Delaware
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

All participants will complete each arm. It is a crossover, randomized design.

Eligibility

Sex/Gender
ALL
Age
22 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy * normal blood pressure

Exclusion criteria

* hypertension * history of heart disease * diabetes * kidney disease * obese (BMI ≥30) * significant weight changes in the last 6 months * use of tobacco products * pregnant * on a special diet (gluten free; vegan) * take any medications for the above conditions * endurance trained athletes

Design outcomes

Primary

MeasureTime frameDescription
Conduit artery endothelial-dependent dilationon the 7th day of each dietThe change in flow-mediated dilation (FMD) between the 3 diets as assessed by brachial artery FMD

Other

MeasureTime frameDescription
Arterial Stiffnesson 7th day of each dietAssessed by carotid to femoral artery pulse wave velocity
Wave reflectionon 7th day of each dietAssessed by augmentation index
Endothelial cell expression of oxidative stress markeron the 7th day of each dietAssessed in venous endothelial cells from participants.
Ambulatory blood pressure7 daysAssessed by 24 hr ambulatory blood pressure monitoring.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026